ClinicalTrials.Veeva

Menu

FlowTriever for Acute Massive Pulmonary Embolism (FLAME)

Inari Medical logo

Inari Medical

Status

Completed

Conditions

PE - Pulmonary Thromboembolism
PE - Pulmonary Embolism

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

To evaluate treatment outcomes of patients diagnosed with high-risk (massive) pulmonary embolism

Enrollment

115 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Age >=18 years Treatment team determines pulmonary embolism is the cause of shock, and the PE is high-risk per the protocol definitions

Exclusion criteria

  • Out of hospital cardiac arrest with Glasgow Coma Scale of ≤8
  • Witnessed cardiac arrest with ongoing CPR >30 minutes
  • Contraindication to anticoagulants, i.e. heparin or alternative
  • Hematocrit <28%
  • Platelets <25,000/μL
  • INR >8
  • Intracardiac thrombus and/or intracardiac clot in transit
  • Known anaphylactic sensitivity to radiographic agents that cannot be pre-treated
  • History of pulmonary hypertension with systolic pulmonary arterial pressure >70 mmHg
  • Presence of chronic medical conditions with estimated < 90 days life expectancy per physician discretion (should not consider the current pulmonary embolism and its treatment)
  • Current participation in another drug or device treatment study that, in the Investigator's opinion, would interfere with participation in this study
  • Patient is known to be COVID-19 positive at hospital admission (patient has active COVID-19)

Trial design

115 participants in 3 patient groups

FlowTriever Arm
Description:
FlowTriever Arm subjects are defined as those subjects where FlowTriever is used as the Primary Treatment for pulmonary embolism.
Context Arm
Description:
Subjects with high-risk pulmonary embolism who are treated with non-FlowTriever therapies.
Prior Therapy Arm
Description:
Subjects presenting with low/intermediate-risk PE who received advanced therapy but subsequently progressed to high-risk PE in the same hospital setting/admission.

Trial documents
2

Trial contacts and locations

11

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems